169 related articles for article (PubMed ID: 36062611)
1. Vasopressin Response and Clinical Trajectory in Septic Shock Patients.
Bauer SR; Sacha GL; Siuba MT; Wang L; Wang X; Scheraga RG; Vachharajani V
J Intensive Care Med; 2023 Mar; 38(3):273-279. PubMed ID: 36062611
[TBL] [Abstract][Full Text] [Related]
2. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
Jakowenko ND; Murata J; Kopp BJ; Erstad BL
J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
[No Abstract] [Full Text] [Related]
3. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Vasopressin Responsiveness in Critically Ill Adults.
Allen B; Kram B; Kram S; Schultheis J; Wolf S; Gilstrap D; Shapiro M
Ann Pharmacother; 2018 Feb; 52(2):126-132. PubMed ID: 28853293
[TBL] [Abstract][Full Text] [Related]
5. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
6. Role of vasopressin in the management of septic shock.
Mutlu GM; Factor P
Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
[TBL] [Abstract][Full Text] [Related]
7. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis.
Huang H; Wu C; Shen Q; Xu H; Fang Y; Mao W
Am J Emerg Med; 2021 Oct; 48():203-208. PubMed ID: 33975132
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic profiles and hemodynamic response after vasopressin initiation in septic shock: A cross-sectional study.
Dugar S; Siuba MT; Sacha GL; Sato R; Moghekar A; Collier P; Grimm RA; Vachharajani V; Bauer SR
J Crit Care; 2023 Aug; 76():154298. PubMed ID: 37030157
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock.
Bauer SR; Sacha GL; Lam SW; Wang L; Reddy AJ; Duggal A; Vachharajani V
J Intensive Care Med; 2022 Jan; 37(1):92-99. PubMed ID: 33251906
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
Menich BE; Miano TA; Patel GP; Hammond DA
Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
[No Abstract] [Full Text] [Related]
12. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
13. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
[TBL] [Abstract][Full Text] [Related]
14. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.
Yerke JR; Sacha GL; Scheraga RG; Culver DA; Abraham S; Torbic H; Lam SW; Ammar MA; Olman MA; Bauer SR
Pharmacotherapy; 2020 Jan; 40(1):33-39. PubMed ID: 31705703
[TBL] [Abstract][Full Text] [Related]
16. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
17. Body Mass's Impact on Response to Fixed-Dose Vasopressin in Patients With Septic Shock.
Torbic H; Sacha GL; Bauer SR; Lam SW
Shock; 2018 Oct; 50(4):388-394. PubMed ID: 29240642
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin and terlipressin in neonates and children with refractory septic shock.
Biban P; Gaffuri M
Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to fixed-dose vasopressin in adult patients with septic shock.
Sacha GL; Lam SW; Duggal A; Torbic H; Bass SN; Welch SC; Butler RS; Bauer SR
Ann Intensive Care; 2018 Mar; 8(1):35. PubMed ID: 29511951
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin infusion in children with catecholamine-resistant septic shock.
Vasudevan A; Lodha R; Kabra SK
Acta Paediatr; 2005 Mar; 94(3):380-3. PubMed ID: 16028663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
